CDA3C660-4E3F-4721-8F1B-A0E87941E356 Created with sketchtool.
Resource Center
May 1, 2020
Vectorious chosen as a 2020 Red Herring Top 100 Europe Winner
Vectorious Blog
After much consideration, the Red Herring judging panel has announced its Top 100 Europe winners this evening, recognizing Europe’s leading private companies and celebrating these startups’...
February 4, 2020
A Novel Implantable Left Atrial Pressure Sensor in Two Heart Failure Patients
EuroIntervention
Monitoring pressure and adapting therapy to the rapid changes of left ventricular loading conditions is the cornerstone of treatment of acute heart failure in hospitalized patients. This approach...
July 25, 2019
Vectorious on MedTech Strategist's July edition: "Guiding Heart Failure Treatment with an In-Heart Left...
Vectorious Blog
Vectorious is proud to be included in the MedTech Strategist (Vol. 6, No. 11 – July 25, 2019) as one of the “Startups to Watch” in the field of heart failure. The article tells the story...
JACC Vectorious
September 1, 2018
JACC reviews Vectorious' study: In Vivo Performance of a Novel Permanently Implanted Left Atrial Pressure...
JACC- Journal of the American College of Cardiology
Vectorious conducted a study which comes to assess the safety, the usability and the feasibility of the V-LAPTM, its novel wireless left atrial pressure sensor, to accurately measure left atrial...
Horizon 2020
April 30, 2018
Vectorious wins Horizon 2020 grant of € 1.8M
Vectorious Blog
Vectorious Medical Technologies has been awarded an SME Instrument Phase 2 grant of €1.8 million under grant agreement No. 811765. The SME Instrument is a programme under the Horizon 2020...
JACC Vectorious
July 18, 2017
JACC review highlights Vectorious implantable haemodynamic monitor
JACC- Journal of the American College of Cardiology
A review appearing in the Journal of the American College of Cardiology (JACC) has highlighted Vectorious Medical Technologies, an Israeli company developing the world’s first digital...
Thank you for subscribing!

Get our latest news and updates!

Subscribe to get Vectorious' Newsletter with the latest news and clinical updates from the VECTOR-HF study